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ABSTRACT Giardia lamblia is a highly prevalent yet understudied protistan parasite
causing significant diarrheal disease worldwide. Hosts ingest Giardia cysts from con-
taminated sources. In the gastrointestinal tract, cysts excyst to become motile tro-
phozoites, colonizing and attaching to the gut epithelium. Trophozoites later differ-
entiate into infectious cysts that are excreted and contaminate the environment.
Due to the limited accessibility of the gut, the temporospatial dynamics of giardiasis
in the host are largely inferred from laboratory culture and thus may not mirror Giar-
dia physiology in the host. Here, we have developed bioluminescent imaging (BLI)
to directly interrogate and quantify the in vivo temporospatial dynamics of Giardia
infection, thereby providing an improved murine model to evaluate anti-Giardia
drugs. Using BLI, we determined that parasites primarily colonize the proximal small
intestine nonuniformly in high-density foci. By imaging encystation-specific biore-
porters, we show that encystation initiates shortly after inoculation and continues
throughout the duration of infection. Encystation also initiates in high-density foci in
the proximal small intestine, and high density contributes to the initiation of encys-
tation in laboratory culture. We suggest that these high-density in vivo foci of colo-
nizing and encysting Giardia likely result in localized disruption to the epithelium. This
more accurate visualization of giardiasis redefines the dynamics of the in vivo Giardia life
cycle, paving the way for future mechanistic studies of density-dependent parasitic pro-
cesses in the host.
IMPORTANCE Giardia is a single-celled parasite causing significant diarrheal disease
in several hundred million people worldwide. Due to limited access to the site of in-
fection in the gastrointestinal tract, our understanding of the dynamics of Giardia in-
fections in the host has remained limited and largely inferred from laboratory cul-
ture. To better understand Giardia physiology and colonization in the host, we
developed imaging methods to quantify Giardia expressing bioluminescent physio-
logical reporters in two relevant animal models. We discovered that parasites primar-
ily colonize and encyst in the proximal small intestine in discrete, high-density foci.
We also show that high parasite density contributes to encystation initiation.
KEYWORDS Giardia, bioluminescence, encystation, parasite, pathogenesis
Giardia lamblia is a unicellular protistan parasite causing acute and chronic diarrhealdisease in over 200 million people worldwide, primarily in developing countries
with inadequate sanitation and water treatment (1). Giardiasis is a serious disease of
children, who may experience substantial morbidity, including diarrhea, malnutrition,
wasting, and developmental delay (2–4). In the United States, giardiasis is the most
frequently diagnosed waterborne diarrheal disease and commonly affects travelers and
immunosuppressed individuals (5). Trophozoites are not invasive, and Giardia infection
does not produce a florid inflammatory response; however, giardiasis is associated with
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villus shortening, enterocyte apoptosis, hypermobility, and intestinal barrier dysfunc-
tion (6). The estimated failure rates of up to 20% for standard drug treatments such as
metronidazole (7) and growing evidence of drug resistance in Giardia (8–10) under-
score the need for new therapeutic treatments of this widespread and neglected
diarrheal disease.
Motile Giardia trophozoites colonize and proliferate in the small intestine (SI) (11),
attaching to the intestinal villi to resist peristalsis using a complex microtubule struc-
ture termed the ventral disc (12, 13). In the gut, trophozoites differentiate into infec-
tious cysts that are eventually excreted and can contaminate water sources in the
environment (5, 14). Disseminated cysts are ingested and excyst into trophozoites after
passage through the stomach, completing their life cycle in the host gastrointestinal
(GI) tract. Trophozoites are proposed to colonize the acidic, cholesterol-rich duodenum
or jejunum and then initiate encystation when peristalsis sweeps them to the alkaline,
cholesterol-depleted distal intestine (15–17). Encystation is thus believed to be trig-
gered via cues that are specific to particular anatomical sites in the gastrointestinal tract
(16, 18) and can be induced in vitro by increasing pH and decreasing cholesterol or by
increasing bile and lactic acid in the medium (16, 19, 20). However, cysts produced in
vitro excyst less efficiently using in vitro excystation protocols (21) and are less robust
at establishing infections in animal models than cysts harvested directly from feces. This
implies that additional host factors are required for infectious cyst production (16). As
differentiation of the trophozoite into the infectious cyst is a critical aspect of Giardia’s
pathogenesis (22), determining the extent of in vivo parasite differentiation to cysts and
subsequent cyst dissemination is key to understanding in vivo host-parasite interac-
tions (23–25).
Despite decades of study, the host-parasite infection dynamics underlying the
extent and progression of acute and chronic giardiasis (4, 26–28) are poorly under-
stood. Due to the limited accessibility of the gastrointestinal tract (15–17), our knowl-
edge of Giardia’s physiology and differentiation in vivo is largely inferred from labora-
tory culture rather than in vivomodels of the disease (15, 17). While in vitro studies have
established that the initiation of encystation is transcriptionally controlled (8–10),
understanding the complex temporospatial dynamics of the parasite life cycle and
interactions with the host remains challenging. In vitro models of giardiasis are not
necessarily adequate proxies for infection within the host as they may not accurately
mirror in vivo parasite physiology. Further, in vitro studies rarely have been confirmed
through analogous in vivo studies of parasite physiology. Thus, in vivo models are
necessary to understand parasite infection dynamics in the host and to evaluate new
antigiardial drugs.
Zoonotic Giardia strains have varied physiologies and have been classified into
assemblages (roughly equivalent to species), including the human isolates from assem-
blages A (e.g., strains WBC6 and DH) and B (e.g., strains GS and H3) (29, 30). Genomes
are available for the assemblage A strains WBC6 (31) and DH (32), the assemblage B
strain GS (32, 33), and some human clinical isolates (34); however, reasonably robust
molecular genetic tools have been developed only for Giardia strains WBC6 and GS (35).
Animal models of giardiasis include adult (36, 37) or suckling (38) mice or adult gerbils
(39) infected with either human Giardia lamblia isolates from assemblage A (strain
WBC6) or assemblage B (strain GS or H3) or murine Giardia muris isolates (40). Infections
with cysts are possible using commercially available assemblage B strain H3 cysts
passaged through gerbils (3); however, strain H3 currently has no genome sequence
and has not been demonstrated to be genetically manipulable. One advantage of using
WBC6 with mice is that both organisms are genetically tractable, and conditions for in
vitro encystation of WBC6 are known; in vitro encystation is not yet possible for the
assemblage B strain GS (15). These limitations and potential differences between
models highlight the need for more direct methods to enumerate parasites in vivo and
quantify in vivo parasite physiology and differentiation.
To assess parasite colonization and differentiation dynamics in the host, we devel-
oped bioluminescent imaging (BLI) methods allowing us to directly quantify and image
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temporal and spatial dynamics of Giardia colonization using the genetically manipula-
ble assemblage A isolate WBC6 (35). Specifically, we have infected mice and gerbils with
WBC6 trophozoites or cysts expressing firefly luciferase (FLuc) under the control of
either constitutive or encystation-specific (41–45) promoters. BLI is used extensively in
diverse animal models and enables sensitive quantification and real-time reporting of
metabolic activity via imaging of the transcriptional activity of promoter-luciferase
fusions (46–48). Protein expression can also be monitored (49). BLI has been used
previously to monitor in vivo parasite metabolism and infection dynamics in animal
models of malaria, leishmaniasis, trypanosomiasis, and toxoplasmosis (50–52), as well as
bacterial colonization of the intestine (41).
Using noninvasive imaging of bioluminescent Giardia parasites, we show real-time
parasite physiology in the host, allowing us to confirm and extend early observations
of G. muris or G. lamblia colonization of the proximal small intestine of mice (53), gerbils
(54), and humans (55). We also improve our understanding of the in vivo Giardia life
cycle, demonstrating that encystation is initiated early in the course of infection, peaks
within the first week, and is correlated with the highest parasite density during
infection. Contrasting studies have reported that parasites colonize the midjejunum of
adult and immunodeficient mice (16) and that parasites encyst in the ileum and colon,
due to the identification of cysts in distal anatomical sites of the gastrointestinal tract
(19, 53).
Last, we demonstrate that high parasite density contributes to the induction of
encystation-specific transcription in vitro. Thus, local regions or foci of high parasite
density in vivo may directly (or indirectly) contribute to the early in vivo differentiation
of parasites that we observed in mice. In total, we show the utility of BLI to evaluate in
vivo Giardia physiology and differentiation in two animal hosts, facilitating quantifiable
longitudinal and spatial monitoring of infection dynamics. BLI has been used exten-
sively to evaluate drugs in numerous parasitic and bacterial infections (56); thus, we
expect that BLI will be equally valuable as an alternative and real-time method to
evaluate antigiardial drugs in relevant animal models of giardiasis.
RESULTS
Visualizing and quantifying Giardia infection dynamics using noninvasive bio-
luminescent imaging in mice. To confirm that the promoter-firefly luciferase (FLuc)
fusions (see Fig. S1 in the supplemental material) are stably integrated and that the
bioluminescence is not lost in the absence of antibiotic selection, we used in vitro
bioluminescence assays to monitor luciferase activity after the removal of antibiotic
selection (Fig. S2B). Both PGDH-FLuc and PCWP1-FLuc strains maintained a consistent
bioluminescence for at least 3 weeks under normal growth conditions (Fig. S2B).
Luciferase catalyzes the production of light in the presence of luciferin substrate. While
oxygen is required for light production, the colon has sufficient oxygen for detectable
light output (57), and D-luciferin delivered by local intraperitoneal injection is rapidly
taken up into the entire gastrointestinal tract within 5 min (58). Because Giardia
trophozoites proliferate in the low-oxygen gut lumen, we tested D-luciferin delivery
both orally (by gavage) and systemically (by intraperitoneal injection) to determine the
delivery method that produced the optimal bioluminescent signal for Giardia coloni-
zation (Fig. S3A). Intraperitoneal injection produced a maximal bioluminescence from
the Giardia bioreporter luciferase strains within 10 min that was stable for over 30 min
after injection (Fig. S3B). Uninfected mice or mice infected with a nonluminescent strain
of Giardia had negligible background signal (Fig. 1A). Last, in vitro bioluminescent
signal intensity of the PGDH-FLuc strain is also directly correlated with parasite density
in culture (Fig. S4). We show that luciferase continues to be expressed at significant and
similar levels both 3 h and 24 h after transfer into encystation medium (Fig. S4).
To query the temporal sequence of in vivo colonization, we infected a cohort of mice
with trophozoites of a constitutive bioreporter strain (PGDH-FLuc) and quantified the
bioluminescent signal over a 14-day time course (Fig. 1). At day 7, we observed
significant bioluminescence compared to uninfected animals (ratio paired t test, P 
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0.0067). Individual mice showed variation in the degree of bioluminescent signal
(Fig. 1A), and some animals exhibited signal periodicity; one representative individual
(Fig. 1B) showed bioluminescence peaks at day 4, day 10, and day 12 postinfection (p.i.).
Maximum bioluminescence occurred between day 4 and day 9 for all animals infected
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FIG 1 Bioluminescent imaging allows noninvasive quantification of Giardia infection dynamics in individual
cohorts of mice. (A) A cohort of four mice was inoculated with the PGDH-FLuc strain, and bioluminescence at 7 days
postinoculation was compared to the background signal from uninfected animals (images at left). PGDH-FLuc
bioluminescence intensity is indicated in the image overlay, with the highest signal intensity (radiance, or
photons/second/square centimeter/steradian) shown in red and the lowest in blue (see scale bar). Bioluminescence
flux (photons/second) rates are compared between the uninfected and infected group, with the asterisks
indicating significance as assessed by the ratio unpaired t test (P  0.05). (B) Cyclic variability of the PGDH-FLuc
bioluminescence is shown in the same animal imaged noninvasively up to 14 days postinfection. (C) Summary of
infection dynamics in two experiments with 8 and 12 mice as quantified by PGDH-FLuc bioluminescence. The
average bioluminescence measured for the cohort each day is shown. The shaded box indicates the maximal
bioluminescent signal, or peak infection range. The average time to maximal bioluminescence after infection with
the PGDH-FLuc strain was 6.6 days. (D) A cohort of four mice was imaged, and flux (photons/second) was quantified
5 days after infection with the PGDH-FLuc strain (Before). The same four mice were imaged, and flux was quantified
2 days after treatment with 50 mg/kg metronidazole by oral gavage (After). The asterisk indicates significance (P
0.05) using an unpaired t test.
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with the PGDH-FLuc strain (n  20 over two experiments) (Fig. 1C). To ensure that the
bioluminescent signal was attributable to metabolically active parasites, we also treated
mice infected with the PGDH-FLuc strain with 50 mg of metronidazole/kg of body weight
by oral gavage. After 2 days of treatment, the bioluminescent signal had decreased to
the same level as that of noninfected animals (Fig. 1D).
Quantifying the spatial variation of Giardia infection using ex vivo imaging of
the murine gastrointestinal tract. To assess spatial infection dynamics and to corre-
late noninvasive imaging with ex vivo imaging of excised intestine, we inoculated 21
mice with 1 million PGDH-FLuc trophozoites. On days 1, 3, 5, 7, 9, 11, and 13 postinfec-
tion, three or four animals were individually imaged. Animals were then sacrificed, and
the gastrointestinal tracts were quickly excised and imaged ex vivo (Fig. 2). We observed
four major patterns of bioluminescence within the gastrointestinal tracts over the
course of infection (representative patterns are shown in Fig. 2A). The majority of
bioluminescent signal occurred in the proximal small intestine as early as 1 day
following oral gavage (Fig. 2B), yet there was some spatial variability in the gastroin-
testinal parasite colonization pattern in the cohorts over the 13 days. Further, we
observed localized areas of maximal bioluminescent signal, or foci, within colonized
regions of the gut (Fig. 2A). These regions are upward of 100-fold more bioluminescent
than adjacent regions in the same anatomical section. In some animals, biolumines-
cence was present in the distal small intestine or diffuse throughout the small intestine.
Less commonly observed was bioluminescence occurring primarily in the cecum or the
large intestine. For all samples, BLI signal intensities of less than 1% of total maximal
signal were seen within the stomach. The in vivo imaging signal intensities were directly
comparable with the ex vivo imaging (Fig. S5).
Through a comparison of colonization patterns during early, mid-, and late infec-
tions (Fig. 2B), we found that early in infection, there was more diffuse small intestinal
colonization, with 48% of the BLI signal from all animals localized to the proximal small
intestine and nearly one-third of signal from the distal small intestine. At maximal
infection (Fig. 1C), the proximal small intestine was more strongly colonized than the
distal, accounting for 71% of overall signal. Four of 11 mice (36%) had a proximal-only
colonization pattern, with an average of 89% proximal signal among the individuals.
Only one mouse had significant colonization of the distal intestine. Late in infection,
higher BLI signal intensity was detected in the distal small intestine and cecum,
although the proximal small intestine still accounted for 57% of overall signal. Early and
late infections were characterized by a more diffuse pattern throughout the gastroin-
testinal tract, whereas during the maximal infection (midinfection), more parasites were
concentrated in the proximal small intestine.
We next interrogated the degree to which the in vivo bioluminescence of the
PGDH-FLuc constitutive bioreporter correlated with parasite abundance using quantita-
tive PCR (qPCR) of a single-copy Giardia gene (Fig. 2C). We determined that there is a
significant and linear association between bioluminescence intensity and infection
density as imaged using the PGDH-FLuc strain (Fig. 2C, P  0.0001). Specifically, follow-
ing ex vivo imaging and quantification of bioluminescence, we quantified total parasites
using qPCR of genomic DNA isolated from 24 1-cm intestinal segments in regions of
high and low bioluminescent signal in four infected animals (Fig. 2C). We amplified the
Giardia pyruvate ferredoxin oxidoreductase gene (PFOR1) and used the constitutively
expressed murine nidogen-1 gene as an internal control to determine the contribution
of murine DNA to total genomic DNA isolated from intestinal segments. A smaller
difference in differential counts to threshold (ΔCT) between nidogen and PFOR genes
indicated greater numbers of parasites, as more murine DNA was present than Giardia
DNA, while a larger difference in ΔCT indicated fewer parasites.
Visualizing and quantifying Giardia temporal and spatial infection dynamics in
Mongolian gerbils. Four gerbils infected with PGDH-FLuc exhibited bioluminescence
and were imaged both noninvasively in vivo and terminally using ex vivo imaging of
isolated gastrointestinal tracts (Fig. 2D). Infected gerbils were strongly bioluminescent
after 8 days of infection, and infections had decreased by 15 days postinoculation. As
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in mice, ex vivo imaging confirmed that Giardia primarily colonized the proximal small
intestine in high-density foci, as seen with localized regions of bioluminescence.
Encystation occurs early in infection in both the proximal and the distal small
intestine in mice. Giardia cysts consist of a partially divided trophozoite surrounded by
a desiccation-resistant cyst wall that is composed predominantly of leucine-rich cyst
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FIG 2 High-density foci of Giardia colonization are present in the proximal small intestine of mice and gerbils. (A)
Representative classes of in vivo and ex vivo bioluminescent images are shown for 24 mice infected with the
PGDH-FLuc strain and sacrificed in cohorts of four on days 3, 5, 7, 9, 11, and 13 postinfection. Photon flux or radiance
(photons/second/square centimeter/steradian) for each intestinal segment is shown and has been normalized to
the maximal ex vivo bioluminescence signal on the radiance scale, yielding the percent total signal per segment.
These values are represented graphically on the grayscale maps below each ex vivo image (white, 0 to 10%; black,
75 to 100%; values between 10% and 75% indicated as shades of gray). A strikethrough indicates greater than 90%
of maximal bioluminescent signal. P, proximal small intestine; D, distal small intestine; C, cecum; L, large intestine.
The stomach (S) is shown for orientation but always lacks bioluminescence. (B) Quantitative bioluminescence
imaging from infections is categorized and summarized by the region of the gastrointestinal tract for all animals
in each phase of infection as early (days 0 to 3), middle (days 5 to 9), and late (days 11 to 13). Shading in each row
of the charts indicates the variations in the maximal bioluminescence in each of the four regions in an individual
animal. (C) Degree to which the in vivo PGDH-FLuc bioluminescence is significantly and linearly correlated in 24
intestinal samples from four infected mice with quantitative PCR measures of Giardia abundance in the same
samples using a single-copy Giardia gene (PFOR1) (normalized to the mouse single-copy nidogen gene). Statistical
significance (R  0.9157, P  0.0001) is noted. (D) The same PGDH-FLuc strain was used to infect two Mongolian
gerbils (see Materials and Methods) without antibiotic pretreatment, and animals were noninvasively imaged over
15 days. Day 8 p.i. and day 15 p.i. noninvasive whole-animal imaging and ex vivo gastrointestinal tract imaging for
day 15 p.i. are shown for both animals (1 and 2) with anatomical annotations as in panels A and B.
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wall proteins (CWPs). CWPs are transported to the outer membrane by encystation-
specific vesicles (ESVs) approximately 2 to 3 h after transfer to in vitro encystation
medium (24, 59). Cyst wall protein 1 (CWP1) expression is upregulated over 100-fold
within 7 h after switching to in vitro encystation medium (60, 61). The bioluminescent
signal from the PCWP1-FLuc strain increased 400-fold when transferred to in vitro
encystation medium (Fig. S2C). We also show that PCWP1-FLuc retains the ability to
upregulate expression from the CWP1 promoter after shifting the strain to encystation
medium following 3 weeks of serial passage of this strain without antibiotic selection
in nonencystation medium (Fig. S2B).
To determine the temporal and spatial dynamics of Giardia encystation in vivo, we
inoculated eight mice with 1 million PCWP1-FLuc-expressing trophozoites. PCWP1-FLuc
bioluminescence was quantified every other day in live animals. One day postinfection,
we observed significant PCWP1-FLuc signal (Fig. 3A), comparable to in vitro transcrip-
tional upregulation of CWP1 (Fig. S2) (24, 61). The maximal bioluminescence from the
PCWP1-FLuc bioreporter occurred at 6 days postinfection, and significantly high biolu-
minescence ranged from 5 to 8 days postinoculation (Fig. 3B). While the PCWP1-FLuc
bioluminescence from all animals was highest within the first week of infection, the
bioluminescence was detectable throughout the 17 days of infection, including day 1
(early infection), day 6 (midinfection), and day 15 (late infection) (Fig. 3).
To determine the regions of the murine gut where encystation is initiated, cohorts
of three animals were sacrificed on days 1, 3, 6, 10, 15, 20, and 26 postinoculation with
the encystation bioreporter strain PCWP1-FLuc, and the entire gastrointestinal (GI) tract
was imaged and scored by region (Fig. 3A). Upregulation of the PCWP1-FLuc encystation
bioreporter was detectable ex vivo as early as day 1 postinfection. Maximal PCWP1-FLuc
bioluminescence was primarily observed in the proximal small intestine, 3 to 5 cm distal
to the stomach, as observed for the constitutive PGDH-FLuc bioreporter strain. Like
PGDH-FLuc, PCWP1-FLuc bioluminescence was often observed as regions of local maxima
or foci within an area of lower bioluminescence (Fig. 2 and 3).
In contrast to the PGDH-FLuc bioreporter strain, bioluminescence from the encysta-
tion bioreporter PCWP1-FLuc was more distributed throughout the small intestine
(Fig. 3A). Early in infection, equal numbers of mice displayed PCWP1-FLuc biolumines-
cence in the proximal and distal small intestines (SIs) (Fig. 3C), and yet the biolumi-
nescence from PCWP1-FLuc localizing to the proximal SI accounted for 50% of total
intensity, whereas the distal SI signal was only 16% of the total bioluminescence in the
gut. At mid- and late infection, proximal and distal SI signal intensities were comparable
(54% and 40%, peak; 37% and 44%, late, respectively) with equal numbers of mice
showing signal from both proximal and distal SI regions.
We also noted increased localization of PCWP1-FLuc bioluminescent signal to the
cecum, compared to PGDH-FLuc, which localized primarily to the proximal small intes-
tine (Fig. 2). Two mice from early infection and one from late infection had strong cecal
bioluminescent signals, sometimes at the exclusion of other anatomical sites, or in
conjunction with bioluminescence elsewhere in the gastrointestinal tract.
Confirmation of encystation initiation in the proximal small intestine during
early infection in mice. To confirm the encystation initiation pattern early in infection,
we infected animals with a second encystation-specific strain, PCWP2-FLuc, containing
the promoter region of the cyst wall protein 2 (CWP2) gene (31). The temporal and
spatial dynamics of encystation initiation that we observed with PCWP2-FLuc were
similar to those of PCWP1-FLuc (Fig. S6).
Because infections with both encystation-specific PCWP1-FLuc and PCWP2-FLuc biore-
porter strains indicated that encystation initiation occurs early during infection and is
primarily localized to the proximal SI, we confirmed the expression of CWP1 transcripts
throughout the gut using qPCR of ex vivo samples following bioluminescent imaging.
Within the first 5 cm of the proximal SI, transcription of CWP1 was upregulated by
3 days postinfection, with significantly more upregulation by day 7 relative to basal
CWP1 transcription levels in in vitro culture (Fig. 4A).
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FIG 3 Encystation initiation occurs early in infection in both the proximal and distal small intestine.
Eighteen mice were inoculated with the PCWP1-FLuc strain, and cohorts of three animals were sacrificed
and imaged on days 1, 3, 6, 10, 15, and 20 postinfection. (A) The whole-animal in vivo images from days
1, 6, and 15, representing early, mid-, and late infection, respectively, are shown with corresponding ex
vivo images from each animal (S, stomach; P, proximal; D, distal; C, cecum; L, large intestine). The stomach
is shown for orientation but always lacks bioluminescence. Days 1 and 15 are presented on a scale
between 1e4 and 1e6 photons/s. Day 6 has the maximal signal, and images are presented using a scale
between 5e5 and 5e7 photons/s. For each ex vivo image, the photon flux (photons/second/square
centimeter/steradian) for each intestinal segment is normalized to the maximal ex vivo bioluminescence
signal on the radiance scale, yielding the percent total signal per segment. Grayscale maps of biolumi-
nescence are shown below each ex vivo image (white, 0 to 10%; black, 75 to 100%; values between 10%
and 75% are indicated as shades of gray). (B) Two cages of mice (n  4 per cage) were inoculated with
the PCWP1-FLuc strain and imaged every other day. The box-whisker plot summarizes bioluminescent
signals for encystation initiation (PCWP1-FLuc) for each phase of infection (early, days 0 to 3; mid-, days 4
to 9; late, days 10 to 20), with the center line indicating the median total flux (photons/second), and the
ends of boxes representing the first and third quartiles below and above the median, respectively. (C) The
spatial localization of signal is summarized for each individual animal in each row. The shaded charts
summarize the percentage of maximal bioluminescent signal from the PCWP1-FLuc strain in each of the
four gastrointestinal regions (P, proximal small intestine; D, distal small intestine; C, cecum; L, large
intestine) for all infected animals in early, middle, and late stages of infection.
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Upregulation of encystation-specific promoter activity results in the commitment of
trophozoites to differentiate into cysts that are shed into the environment to infect new
hosts (61). Hallmarks of this commitment to encystation include the upregulation of
CWP1 and CWP2 genes and the appearance of encystation-specific vesicles (ESVs) that
transport the cyst wall proteins (e.g., CWP1 and CWP2) to build the cyst wall (62, 63).
We find that in vivo CWP1 gene expression corresponds to the in vivo BLI signal of the
PCWP1-FLuc strain. As previously shown in Fig. 3, the PCWP1-FLuc bioluminescence is
localized in foci throughout in the proximal and distal small intestine (Fig. 4B). We
observed a significant increase in CWP1 gene expression (relative to glyceraldehyde-
3-phosphate dehydrogenase [GAPDH]) in these foci of the distal small intestinal and
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FIG 4 CWP1 qPCR and immunostaining of ESVs verify encystation in the proximal and distal small
intestine. (A) Quantitative PCR was used to compare the in vivo expression of CWP1 relative to GAPDH
(CWP1/GAPDH) in the first 5 cm of the small intestine at days 3 and 7 p.i. to that of a confluent in vitro
culture. (B) A representative animal infected with the PCWP1-FLuc strain is imaged noninvasively at day
7 p.i., and ex vivo BLI of the gastrointestinal tract (P, proximal small intestine; D, distal small intestine; C,
cecum; L, large intestine; S, stomach) is shown with corresponding CWP1/GAPDH qPCR of representative
proximal and distal small intestine regions (boxed). (C) Encystation-specific vesicles (ESVs) were immu-
nostained using an anti-CWP1 antibody and quantified in pooled ex vivo samples from two animals each
at days 3 and 7 p.i. ESVs are marked by arrowheads in representative images from each respective
intestinal sample. The percentages of trophozoites positive for ESVs are shown as a percentage of total
trophozoites imaged (n  600 cells counted) in regions of the proximal small intestine and distal small
intestine. Asterisks indicate statistical significance using unpaired t tests with Welch’s correction; *, P 
0.05; **, P  0.005, compared to in vitro culture.
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proximal small intestinal regions. Specifically, we quantified 8-fold- and 19-fold-higher
CWP1 gene expression in the proximal and distal small intestine, respectively, relative
to GAPDH expression.
During in vitro encystation, ESVs appear within several hours following transfer to
encystation medium (18, 21, 61). On days 3 and 7 postinfection, we immunostained the
contents of ex vivo intestinal samples using an anti-CWP1 antibody (63) and confirmed
that trophozoites with encystation-specific vesicles (ESVs) were also present through-
out the small intestine (Fig. 4C). CWP1-positive cells represented approximately 80% of
the total cells imaged in the distal small intestine (Fig. 4C). Specifically, each trophozoite
examined from the small intestine had over 20 ESVs per cell (representative images in
Fig. 4C).
Infection dynamics are similar when trophozoite inoculum size is varied and
when infection is initiated with cysts. Ex vivo spatial imaging of bioluminescence
showed that trophozoite colonization of the host gut is not uniform; rather, vegetative
and encysting trophozoites are concentrated in foci, primarily within the proximal small
intestine (Fig. 2, 3, and S6). Localized areas of increased parasite density might affect
the physiology or differentiation of parasites in this particular region, perhaps contrib-
uting to developmental transitions. To assess whether the observed encystation pro-
moter activity in mice was a consequence of initial concentrations of trophozoites used
during gavage, we inoculated cohorts of mice (n 4 mice per group, n 12 total) with
three different densities of PCWP1-FLuc trophozoites (Fig. 5A). PCWP1-FLuc signal intensity
was dependent on inoculum density during the first 6 days postinoculation. After day
6, the bioluminescent signal reached maxima that were similar for all three inoculum
densities, with a slight and gradual decline over the next 2 weeks (Fig. 5A). Of eight
mice imaged daily for 14 days, the maximum bioluminescence was reached at an
average of 6 days, with a range between 5 and 8 days. At day 21 postinfection,
regardless of initial inoculation density, the ex vivo bioluminescent signal primarily
remained in the proximal and distal small intestine (Fig. 5B), although some animals
had distal or cecum bioluminescence. We suggest that once the initial inoculum
reaches a colonization density threshold, perhaps localized to foci, encystation initia-
tion occurs at the maximal level.
Giardia infections are routinely initiated by ingesting cysts. We isolated PGDH-FLuc or
PCWP1-FLuc cysts from feces of mice in order to evaluate infection dynamics and the use
of BLI when infecting with a low number of cysts (100 cysts/mouse). Similarly to
infection with trophozoites, we observed areas of local signal maxima throughout the
gastrointestinal tract for both strains (Fig. 5C and D). Giardia colonization after infection
with cysts tended to be more distal, and parasites colonized the cecum in each case
(Fig. 5C). Encystation-specific signal (PCWP1-FLuc, Fig. 5D) was observed as early as 1 day
postinfection.
Increased parasite density contributes to encystation initiation. To evaluate
whether parasite density had an effect on the initiation of encystation in vitro, we
“crowded” cultures of the constitutive bioreporter (PGDH-FLuc) strain (Fig. 6A) or the
encystation-specific bioreporter (PCWP1-FLuc) strain (9 h, Fig. 6B) with increasing
amounts of nonluminescent wild-type WBC6 in encystation buffer (Fig. S7). We then
quantified bioluminescence at 3, 6, 9, and 12 h after transfer to encystation medium
(9 h [Fig. 6] and 3 to 12 h [Fig. S7]). Within 9 h, we observed a significant increase in
bioluminescence from the PCWP1-FLuc strain with the addition of 5  105 to 2  106
additional nonluminescent WBC6 trophozoites to the PCWP1-FLuc strain (Fig. 6B). We
observed no increase in bioluminescence with crowding of the PGDH-FLuc strain
(Fig. 6A).
To verify that the observed density-dependent increase in PCWP1-FLuc signal results
in a higher proportion of encysting cells, we quantified the proportion of ESV-positive
cells in wells containing only luminescent cells (100,000 PCWP1-FLuc cells) compared to
more crowded wells (100,000 PCWP1-FLuc cells with 500,000 WBC6 cells) after 9 h in
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encystation medium (Fig. 6C and D). Crowded wells contained a significantly higher
proportion of ESV-positive cells than less crowded wells (Fig. 6E).
DISCUSSION
Limitations and potential differences between different animal models of giardiasis
underscore the need to quantify in vivo Giardia physiology and differentiation beyond
just enumeration of trophozoites and cysts. Parasite burden in mice has been most
FIG 5 Variations in trophozoite inoculation density or infections with cysts result in similar temporal and spatial
dynamics. (A) To assess the impact of cell density on the initiation of encystation, cohorts of three mice were
infected with three different concentrations of PCWP1-FLuc strain trophozoites (80, 8,000, or 80,000), and biolumi-
nescence was imaged and quantified daily over 21 days in total. (B) In vivo and ex vivo BLI is presented following
sacrifice at day 21 p.i. for each inoculation density. The shaded charts summarize the percentage of maximal
bioluminescent signal from the PCWP1-FLuc strain in each of the four gastrointestinal regions (P, proximal small
intestine; D, distal small intestine; C, cecum; L, large intestine) for each individual animal infected with that initial
inoculum. The stomach (S) is shown for orientation but always lacks bioluminescence. (C) A cohort of mice was
infected with the PGDH-FLuc strain. Cysts were harvested throughout the infection from feces (see Materials and
Methods), and 100 cysts were used to infect an additional cohort. Noninvasive imaging of infections using
whole-animal BLI and ex vivo imaging of the gastrointestinal tract are shown for days 1 and 11 p.i. (D) A similar
study was performed using the encystation-specific PCWP1-FLuc strain (days 1 and 7 p.i. shown).
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commonly quantified by directly counting trophozoites or, more recently, by Giardia-
specific qPCR of intestinal segments (3, 64). In live animals, quantification of fecal cysts
is commonly used to estimate parasite abundance, yet cyst shedding is not necessarily
a proxy for overall parasite burden or metabolic activity (65).
Overall, bioluminescence imaging of Giardia infection provides a real-time, temporal
and spatial interrogation of parasite metabolic activity and differentiation (Fig. 1, 2, and
3). We have shown that bioluminescence imaging of an integrated luciferase reporter
construct driven by the native glutamate dehydrogenase (GDH) promoter directly
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FIG 6 Increased cell density contributes to encystation initiation and upregulation of CWP1 expression.
(A and B) Bioluminescence is quantified from an experiment in which 100,000 bioluminescent PGDH-FLuc
(A) or PCWP1-FLuc (B) trophozoites were incubated up to 12 h in encystation medium, and each well was
crowded with increasing numbers (darker-shaded dots) of nonbioluminescent WBC6 parasites (see
Materials and Methods). The 9-h time point is shown for both strains; additional time points are
presented in Fig. S7 in the supplemental material. *, P  0.05; **, P  0.01. (C and D) Representative
images are presented showing the quantification of ESV-positive cells with no nonluminescent WBC6
(wild-type) trophozoites added to 100,000 PCWP-FLuc strain trophozoites (C) or when 500,000 WBC6
(wild-type) trophozoites were added to 100,000 PCWP-FLuc strain trophozoites (D). Insets show represen-
tative images of ESVs (100 per cell on average) stained with an anti-CWP1 antibody. Bars, 5 m. (E)
Percentages of ESV-positive cells after 9 h of incubation in encystation medium are compared for the two
conditions (C and D). The asterisk indicates significant differences between the two conditions as
assessed by the ratio unpaired t test (P  0.05).
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correlated with in vivo parasite density in mice (Fig. 2C). Importantly, we show that
luciferase expression from the GDH promoter continues at significant levels for at least
24 h after the PGDH-FLuc strain is transferred to encystation medium (see Fig. S4 in the
supplemental material). Thus, BLI of constitutive metabolic genes could also be used as
a proxy for Giardia abundance when properly calibrated to other methods of parasite
enumeration.
Using the constitutively expressed PGDH-FLuc strain, we confirmed maximal infection
at approximately 7 days, consistent with prior studies of giardiasis in mice (36). This
live-imaging strategy provides the first real-time visualization of the spatial and tem-
poral dynamics of giardiasis in vivo, allowing us to assess the timing and location of
parasite differentiation. Noninvasive in vivo BLI relies on the external detection of light
produced internally, and signal intensity may be limited by the overall level of luciferase
expression, the oxygen tension within relevant tissues, pigmentation of organs and
skin, or any background signal from the animal (42). However, the gut is sufficiently
oxygenated to permit signal detection, and while animal tissues exhibit relatively high
background levels of autofluorescence, they have nearly nonexistent levels of autolu-
minescence, which facilitates detection even at low signal strength (42, 44, 66).
Giardia cysts are shed sporadically and sometimes cyclically (67, 68). As reported in
human giardiasis (69), we observed variability in infections between isogenic cage
mates, including variations in the time to maximum infection and spatial colonization
patterns, and cyclical infections (Fig. 1 to 3). We confirmed that early infection dynamics
vary based on the number of trophozoites inoculated or if cysts are used to initiate the
infection, but that as a whole and as previously reported, parasite burden peaks at
about 1 week after infection and is most commonly associated with the proximal and
distal small intestine (Fig. 5).
Reassessing the spatial dynamics of Giardia physiology and differentiation in
two animal hosts. The convoluted route of the animal gut and the diffusion and
refraction of bioluminescence present a challenge when imaging Giardia infections in
live animals (41). Differentiating localized parasite activity from diffuse infection using
in vivo optical imaging is also challenging (Fig. 1 and 2).
Giardia colonizes the gastrointestinal tract of both mice and gerbils with a localized
or “patchy” distribution, as has been observed for many other pathogens of the
gastrointestinal tract or other organs (50–52, 66, 70). We show that Giardia, rather than
uniformly colonizing throughout a region of the GI tract, colonizes the intestine in
discrete foci (Fig. 2). Based on early studies using direct counting of trophozoites from
intestinal samples, Giardia has generally been assumed to primarily colonize the
midjejunum, or middle section of the small intestine (16, 53, 71), although other early
work suggested that trophozoites prefer to colonize throughout the proximal small
intestine (16). We suggest that BLI-directed ex vivo sampling of high-density Giardia foci
could improve the accuracy and sensitivity of subsequent histological or physiological
analyses.
Encystation initiation also occurs in discrete foci within the proximal and distal small
intestine, or occasionally the cecum (Fig. 3 and S6). Using ex vivo BLI, we imaged
discrete foci of encysting trophozoites in the proximal small intestine and less com-
monly in the cecum, and foci were never present in the large intestine. These obser-
vations challenge conventional assumptions that chemical cues in the distal gut are
solely responsible for the initiation of in vivo trophozoite differentiation to the cyst in
the Giardia life cycle. We found that metabolically active trophozoites are predomi-
nantly located in the proximal small intestine, with areas of local intensity frequently
just distal to the pylorus (Fig. 2 and 3). We also observed spatial variability between
individuals, from diffuse infection throughout the small intestine to patchy foci only in
the distal small intestine or cecum. Maximal bioluminescence (and thus infection)
correlated strongly with proximal small intestinal colonization, whereas developing or
clearing infections were present more diffusely throughout the gastrointestinal tract
(Fig. 2 and 3).
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The Mongolian gerbil or jird (Meriones unguiculatus) is a less commonly used, yet
promising animal model for giardiasis (72). Gerbils are often used in the study of both
bacterial infections (73, 74) and parasitic infections (75, 76). Gerbils are readily infected
by both assemblage A (WBC6) and assemblage B (GS) strains, though infection clear-
ance is delayed with GS (40). Gerbils infected with Giardia have been noted to exhibit
comparable infection time courses regardless of inoculation stage (cysts versus tropho-
zoites) or site (intragastric versus duodenal) (72). Most notably, in contrast to mice,
gerbils do not require antibiotic pretreatment to develop robust infections with the
WBC6 strain and also have symptoms of giardiasis consistent with human infection,
including wasting, impaired small intestinal disaccharidase activities, and reduced
microvillus border surface (77). Here, we show that the constitutive bioreporter PGDH-
FLuc has similar localizations to the proximal small intestine in both mice and gerbils
(Fig. 2D), and the reported infection dynamics are similar to that observed in humans
(67). Though gerbils provide an excellent model system to study assemblage A or B
infections in a natural host, there are no genetic tools available for gerbils. We expect
future studies to directly compare infection dynamics in different animal hosts using
the same bioreporter strains with subsequent BLI.
High-density foci of parasites contribute to encystation initiation. The prevail-
ing view of trophozoite differentiation to cysts in the host has been extrapolated from
the chemistry of the gut region where trophozoites were previously believed to encyst
(15–17). Parasite commitments to encystation and excystation are key events in Giar-
dia’s life cycle, and it is clear that these transitions are highly regulated (61). Premature
or tardy encystation can limit cyst development, proliferation, transmission into the
environment, and dissemination to new hosts (65). The transition to the cyst form
begins with detection of encystation stimuli, resulting in transcriptional upregulation of
encystation-specific cyst wall proteins (CWPs) (24, 59). Almost 30 years ago, Gillin et al.
showed that elevated bile concentrations could induce encystation in in vitro culture
(19, 71). When these in vitro encystation protocols are used, CWPs are transported to
the outer membrane via encystation-specific vesicles (ESVs) within roughly 6 h of
exposure to encystation stimuli (24, 59). However, differentiation to cysts can be
induced even in the absence of bile, and several in vitro culture protocols have been
developed to induce encystation by modifying pH, bile, lactic acid, and lipid concen-
trations in culture (17, 24). Importantly, no in vitro encystation protocol produces a high
abundance of infectious cysts, suggesting that in vitro encystation may not accurately
recapitulate differentiation in vivo.
Our quantitative in vivo imaging of temporal and spatial dynamics of parasite
proliferation and encystation implies that there could be other factors contributing to
Giardia’s developmental transitions during its life cycle in the host. Rather than encys-
tation uniformly occurring throughout a particular region of the gut, we observed
nonuniform foci of bioluminescence in infections with CWP1 and CWP2 strains (Fig. 3
and S6). We also detected significant expression of CWP1 in ex vivo samples associated
with increased bioluminescence in both the proximal and distal small intestine (Fig. 4B).
Last, we confirmed the presence of ESVs in trophozoites isolated from the proximal and
distal small intestine (Fig. 4), indicating that encystation is initiated and proceeds
normally in these regions. In contrast with prior studies, this initiation of encystation
occurred early in infections in the proximal small intestine (Fig. 3) and peaked within
the same time as maximal parasite density observed using the constitutively expressed
PGDH-FLuc bioreporter strain (Fig. 1). While there was initial variation in the encystation
bioluminescent signal proportional to the amount of initial inoculum, we saw that the
encystation-specific BLI signal peaked at about 7 days and the encystation BLI signal
persisted throughout the 21 days of infection for all inoculum densities (Fig. 5A).
Pathogens have evolved to take advantage of the discrete mucosal surfaces and
functions associated with the various anatomical regions of the mammalian gut (78).
Reaching a particular threshold of cell density is known to either directly or indirectly
modulate developmental programs in diverse parasitic (79–81) and free-living (82)
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eukaryotes. Density-dependent quorum sensing is key to slender-to-stumpy differen-
tiation in trypanosomes, for example, and trypanosomes can also respond to or affect
bacterial quorum sensing signals (80, 81). Parasites such as Giardia detect and respond
to a variety of chemical and environmental cues during their life cycles, and Giardia has
been shown to respond to alterations in lipid and pH concentrations in vitro, triggering
encystation. Alternatively, foci of high parasite density could limit local concentrations
of nutrients or metabolites or alter local pH—all of which are reported stimuli for
encystation initiation (61). This model of localized parasite density-induced encystation
due to the localized depletion of nutrients or accumulation of waste products is
congruent with observed in vitro contributions of pH and/or lipid starvation to encys-
tation initiation (15–17).
By quantifying both CWP1 expression and the proportion of ESV-positive cells
(Fig. 6), we show that high parasite density contributes in part to the initiation of
encystation in vitro. Encystation thus may be initiated in vivo in localized areas of the
gut within the discrete high-density regions of Giardia colonization (Fig. 3 and 5). We
suggest that the nonuniform foci of encystation-specific bioluminescence represent
“hot spots” of encystation in the gut. Compared to regions colonized with a lower
parasite density, higher-density Giardia foci could directly impact the local chemistry of
the gut, the commensal microbiome, or the host epithelium (Fig. 2). While we observe
some initiation of encystation within the 1st day of infection (Fig. 3), the overall process
of encystation in the host is lengthy, and it may take hours before mature, infectious
cysts are observed in the large intestine or are recovered in feces. Further character-
ization of parasite physiology and differentiation in high-density foci compared to
low-density regions of colonization will help to elucidate the contribution of parasite
density to Giardia’s developmental transitions.
A new tool for evaluating chronic giardiasis and for antigiardial drug screen-
ing. Human giardiasis typically resolves within a few weeks, yet chronic or variable
infections can occur (83) and have been linked to impaired physical and cognitive
development in children (6). In vivo BLI offers both real-time and long-term or longi-
tudinal monitoring of the infection dynamics in mice or gerbils. We monitored and
quantified the extent of variation in the in vivo expression of Giardia metabolic and
encystation genes for up to 3 weeks using cohorts of mice infected with one of three
Giardia bioluminescent reporter strains (PGDH-FLuc, PCWP1-FLuc, or PCWP2-FLuc). As we
have shown, BLI of Giardia infection dynamics provides a robust method to estimate
variance within such cohorts of study animals. Defining the range and variation of
Giardia colonization in animals is essential before performing a power analysis to
determine the numbers of animals that would be statistically informative. In addition,
animal numbers can be reduced with longitudinal BLI of giardiasis—a primary goal of
ethical animal use in research (42, 84). We anticipate that the use of dual- or triple-
spectrum bioreporter strains (85–87) will permit simultaneous visualization of two or
more Giardia processes (e.g., metabolic activity and encystation) in the same study
animal.
Growing evidence of drug resistance in Giardia underscores the need to develop
new therapeutic alternatives for the treatment of giardiasis (83), and in vivo biolumi-
nescence imaging of murine or gerbil Giardia infections will aid in the evaluation of
promising antigiardial drug candidates. As we have shown, the BLI of luciferase-
expressing strains not only facilitates the monitoring of parasite burden but can also
provide real-time information on other aspects of parasite physiology and metabolism.
We have validated the use of BLI for the analysis of anti-Giardia drugs by demonstrating
that metronidazole, the standard-of-care anti-Giardia drug that targets parasite meta-
bolic activity (88), reduced in vivo bioluminescence of the constitutively expressing
PGDH-FLuc bioreporter strain. Other bioluminescent reporter strains could be utilized for
high-throughput in vitro screens of candidate drugs, prior to in vivo assessment in
animal models. BLI studies with anti-Giardia drugs targeting nonmetabolic parasitic
cellular processes (e.g., motility or encystation) could identify adjunct or complemen-
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tary treatments that reduce parasite proliferation, infection duration, or cyst dissemi-
nation.
MATERIALS AND METHODS
Luciferase strain construction and validation. We created three strains of Giardia lamblia WBC6,
each with firefly luciferase (FLuc) driven by a specific Giardia gene promoter (see Fig. S1 in the
supplemental material). FLuc promoter fusion constructs were integrated into the genome as previously
described (45). To quantify colonization and metabolic activity, we integrated a construct containing
FLuc driven by the constitutive NADP-specific glutamate dehydrogenase (GiardiaDB GL50803_21942)
promoter (PGDH-FLuc) (Fig. S1A). To quantify in vivo encystation dynamics, we integrated constructs
containing FLuc with the encystation-specific cyst wall protein 1 (GiardiaDB GL50803_5638) promoter
(PCWP1-FLuc) and the encystation-specific cyst wall protein 2 (GiardiaDB GL50803_5435) promoter (PCWP2-
FLuc) (Fig. S1B and C). Briefly, a vector previously used to integrate hemagglutinin (HA)-tagged aurora
kinase (89) was modified to contain the coding sequence for firefly luciferase fused to the GDH, CWP1,
or CWP2 promoter. Puromycin (Purr) and ampicillin (Ampr) resistance cassettes allowed selection in
Giardia and Escherichia coli, respectively. The vector was linearized using MluI, and 10 g of DNA was
electroporated into Giardia lamblia strain WBC6 (45). Transfected cells were selected for 7 to 10 days
using puromycin (50 g/ml). Confirmation of successful genomic integration was obtained by PCR
amplification (data not shown), as well as in vitro bioluminescence assays in vegetative cells (PGDH-FLuc)
and encysting strains (PCWP1-FLuc and PCWP2-FLuc) (Fig. S2).
Giardia trophozoite and encystation culture conditions. G. lamblia (ATCC 50803) WBC6 PGDH-FLuc,
PCWP1-FLuc, and PCWP2-FLuc strains were cultured in modified TYI-S-33 medium supplemented with
bovine bile and 5% adult and 5% fetal bovine serum (56) in sterile 16-ml screw-cap disposable tubes (BD
Falcon) and incubated upright at 37°C without shaking. Encystation was induced in vitro by decanting
TYI-S-33 medium from 24-h cultures (roughly 30% confluent) and replacing it with encystation medium
modified by the addition of 0.5 g/liter bovine bile, pH 7.8 (61). After 24 h, cysts settled at the bottom of
the tube.
Giardia in vitro bioluminescence and density dependence assay. To assess the stability of
luciferase signal in integrated promoter-FLuc strains without selection, luciferase expression in the
PGDH-FLuc and PCWP1-FLuc strains was determined before and after passage of the cells in the absence of
antibiotic selection (1:25 dilutions daily for 3 weeks). Confluent tubes were incubated on ice for 15 min
to fully detach cells. Cells were pelleted by centrifugation at 900  g for 5 min and resuspended in 1 ml
of fresh TYI-S-33 medium supplemented with 150 g/ml D-luciferin (PerkinElmer). Aliquots (50 l, three
technical replicates) were added to white opaque 96-well microplates (PerkinElmer). Bioluminescence
was analyzed on a Victor3 plate reader using 1-s exposures until maximum signal was achieved.
For density dependence assays, wild-type and PCWP1-FLuc cells were grown to confluence, harvested
as described above, and washed and resuspended in encystation medium. One hundred thousand
PCWP1-FLuc cells were plated in each well of a microplate, and a range of dilutions of nonbioluminescent
wild-type WBC6 was added to the PCWP1-FLuc cells in three technical replicates. Encystation medium was
then added to adjust the final volume to 200 l per well. Microplates were individually sealed in type A
Bio-Bags (BD) to maintain an anoxic environment and incubated at 37°C for the indicated time points.
D-Luciferin was added to 150 g/ml, and luciferase activity was analyzed as described previously.
Noninvasive in vivo bioluminescent imaging of Giardia colonization and encystation in mice
and gerbils. Eight-week-old female C57/B6/J mice (Jackson Laboratory) were maintained on ad libitum
water and alfalfa-free irradiated rodent pellets (Teklad 2918). To promote parasite colonization, water was
supplemented with 1 mg/ml ampicillin and neomycin (Teknova) for 5 days prior to infection (64). Water
bottles were kept protected from light to minimize degradation of the antibiotics, and antibiotics were
refreshed every other day. Individual mice were marked with ear tags or permanent marker on tails, and
hair was removed from the ventral abdomen to facilitate imaging. Each mouse was first shaved using a
commercial men’s groomer, and then depilatory cream (Nair) was applied for 30 s. For long-term studies,
depilatory cream was reapplied as necessary to maintain a hairless ventral abdomen (41). Each animal
was gavaged with 1  107 G. lamblia trophozoites in 100 l phosphate-buffered saline as previously
described (90). Four- to 6-week-old female Mongolian gerbils (Charles River, Inc.) were maintained as
described above except that no antibiotics were supplied to the water. All animal studies were
performed with IACUC approval at the University of California, Davis (Scott C. Dawson, Principal
Investigator [PI]).
For in vivo BLI, animals were sedated using isoflurane (1.5 to 3%) in an induction chamber. D-Luciferin
(30 mg/kg of body weight) was then injected intraperitoneally at a dose of 150 mg/kg (total volume
injected, 100 l). Sedated animals were transferred to an optically clear XIC-3 isolation chamber
(PerkinElmer) and positioned on their dorsal surface. Bioluminescence was imaged using an IVIS
Spectrum (PerkinElmer) with no emission filter. Anesthesia was maintained with 1.5 to 2% isoflurane and
100% oxygen during imaging.
Photons were quantified using an ultrasensitive charge-coupled device (CCD) camera (IVIS Spec-
trum), and the resulting heat maps of bioluminescent photon emission intensity were overlaid on still
images of anesthetized animals. To allow the D-luciferin to distribute throughout the body, images were
collected with 2-min exposures constantly over 8 to 10 min until the bioluminescent signal stabilized.
The final image collection was performed with 2- to 5-min exposures, dependent on signal strength.
Region of interest (ROI) analysis was used to quantify bioluminescence (Living Image). A rectangle
encompassing the entire abdomen was drawn for each animal from front paws to anus. BLI data were
quantified as total flux (photons/second) for exposure time-independent quantification of signal inten-
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sity. For animals infected with PGDH-FLuc, the minimal signal was normalized to the level of background
signal in uninfected mice (1  104 photons/s). Because the bioluminescent signal intensity from mice
infected with PCWP1-FLuc was several orders of magnitude stronger than that for mice infected with for
PGDH-FLuc, the minimal threshold signal was adjusted to 5  105 photons/s in order to minimize
background.
Ex vivo bioluminescence imaging in mice and gerbils. Sedated animals were euthanized by
cervical dislocation. The gastrointestinal tract was quickly dissected from esophagus to anus and
positioned within a plastic petri dish. The dish and contents were placed within the XIC-3 isolation
chamber, 2.5% oxygen was provided to maximize signal, and the GI tract was imaged with a 30-s
exposure. Ex vivo imaging was performed less than 30 min after the initial injection of luciferin. ROI
analysis was used to quantify bioluminescence (Living Image). Total gastrointestinal tract signal was
analyzed with a circle over the entirety of the petri dish. The stomach, proximal SI (first half), distal SI
(second half), cecum, and large intestine were traced using the freehand tool.
Giardia cyst collection from murine feces. Cysts were isolated as previously described (91). Mice
were infected with either strain PGDH-FLuc or strain PCWP1-FLuc as described above. Fresh stool was
acquired daily by immediate collection after feces exited the animal and was stored at 4°C. After 7 days,
a total of 3 g of feces was collected from animals infected with either strain PGDH-FLuc or strain PCWP1-FLuc.
Fecal samples were suspended in 10 ml tap water, broken up with a tongue depressor, and filtered
through a tea strainer. Fecal solution (5 ml) was layered onto an equal volume of chilled 0.75 M sucrose
in a 15-ml Falcon tube. Samples were centrifuged for 5 min at 400  g, and 2 ml of cyst-containing
solution was removed from the water-sucrose interface with a sterile transfer pipette. Cysts were
quantified visually using a hemacytometer and were diluted to 1,000 cysts/ml with tap water. Cysts were
stored at 4°C until use.
Correlation of in vivo parasite density with bioluminescence using qPCR. One-centimeter
segments from a region showing strong ex vivo signal were identified, marked in the Living Image
software, excised, and flash frozen in liquid nitrogen. Total genomic DNA was extracted using standard
methods (92) and diluted to 10 ng/l in nuclease-free water prior to quantitative PCR (qPCR). Quanti-
tative PCR of the pyruvate-ferredoxin oxidoreductase-1 (PFOR1, GiardiaDB GL50803_17063) gene (88)
was performed using Pfor1F (5=TTCCTCGAAGATCAAGTTCCGCGT3=) and Pfor1R (5=TGCCCTGGGTGAACT
GAAGAGAAT3=) oligonucleotide primers and SensiFAST No-ROX SYBR green master mix in an MJ Opticon
thermal cycler, with an initial 2-min denaturation step at 95°C followed by 40 cycles of 95°C for 5 s, 60°C
for 10, and 72°C for 10. The single-copy, constitutively expressed murine nidogen-1 (nid1) gene was used
as an internal control to quantify the contribution of murine DNA to intestinal segments (qPCR primers
nidoF [5=CCAGCCACAGAATACCATCC3=] and nidoR [5=GGACATACTCTGCTGCCATC3=]). The differential
counts to threshold (ΔCT) between nid1 and pfor1 were quantified, and CT values were determined using
the Opticon Monitor software.
Confirmation of encystation in the proximal small intestine during early infection using qPCR.
A cohort of four mice was infected with PCWP1-FLuc, and two mice were imaged and sacrificed for sample
collection at both day 3 and day 7 postinfection (p.i.). Following ex vivo imaging, intestines from infected
mice were dissected into 3-cm segments, immediately frozen in liquid nitrogen, and transferred to an
80°C freezer until used for RNA extraction. RNA from intestinal segments was purified using RNA
Stat-60 (Tel-Test, Inc.). RNA quality was assessed using spectrophotometric analysis (NanoDrop Technol-
ogies) and electrophoresis prior to cDNA synthesis. Double-stranded cDNA was synthesized using the
QuantiTect reverse transcription kit (Qiagen). Quantitative PCR of cyst wall protein 1 (CWP1, GiardiaDB
GL50803_5638) was performed using cwp1F (5= TAGGCTGCTTCCCACTTTTGAG 3=) and cwp1R (5= AGGT
GGAGCTCCTTGAGAAATTG 3=) oligonucleotide primers (93) and SensiFAST No-ROX SYBR green master
mix in an MJ Opticon thermal cycler, with an initial 2-min denaturation step at 95°C followed by 40 cycles
of 95°C for 5 s, 60°C for 10 s, and 72°C for 10 s. The constitutively expressed gene for glyceraldehyde-
3-phosphate dehydrogenase (GAPDH; GiardiaDB GL50803_ 6687) was chosen as an internal reference
gene and was amplified with gapdh-F (5= CCCTTCACGGACTGTGAGTA 3=) and gapdh-R (5= ATCTCCTCG
GGCTTCATAGA 3=) oligonucleotide primers. CT values were determined using the Opticon Monitor
software, and statistical analyses were conducted using Prism (GraphPad).
Immunostaining of encysting trophozoites in intestinal tissue samples and in vitro crowding
assays. Intestinal segments from the same infected mice analyzed with qPCR (above) were fixed using
1% paraformaldehyde in 1 HEPES-buffered saline (HBS) as previously described (94). Samples were
vortexed to facilitate removal of luminal contents, and supernatant was applied to poly-L-lysine-coated
coverslips. Cells were permeabilized in 0.1% Triton X-100 for 10 min. Coverslips were washed three times
with 2 ml of PEM buffer (0.1 M PIPES, pH 6.9, 2 mM EGTA, 1 mM MgSO4). Immunostaining was performed
with a mouse primary antibody to cyst wall protein 1 (Giardi-a-Glo; Waterborne, Inc.) and a donkey
anti-mouse secondary antibody conjugated to an Alexa 350 fluorophore (Invitrogen). Cells from crowd-
ing experiments were fixed by adding a final concentration of 1% paraformaldehyde directly to plate
wells. Cells were washed in PEM buffer, and staining was performed as described above.
Images were acquired via automated MetaMorph image acquisition software (MDS Technologies)
using a Leica DMI 6000 wide-field inverted fluorescence microscope with a PlanApo 100, 1.40-
numerical-aperture (NA) oil immersion objective. At least 100 trophozoites were counted per slide, and
cells were binned into encysting or normal trophozoite morphologies. Regions of small intestine were
distinguished spatially as follows: proximal, 1 to 16 cm; and distal, 17 to 32 cm. Slides from 3 to 6 separate
intestinal segments were counted per spatial bin. The statistical significance of differences in cell number
between the spatial bins was determined via Student’s t test.
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Accession number(s). Plasmid sequence data have been deposited in GenBank under accession
numbers MF062155 to MF062157.
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